Optimum Clinical is categorized under Nonmetallic Minerals Development and Test Boring in Amarillo, TX and active since 2012.
Optimum Clinical was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Nonmetallic Minerals Development and Test Boring business, which does work in the B2B market, and is classified as a Nonmetallic Minerals Development and Test Boring, under code number 213115 by the NAICS.
If you are seeking more information, feel free to contact Linda Loeffelbein at the company’s single location by writing to 2318 Atkinsen St, Amarillo, Texas TX 79106 or by phoning (913) 689-9265. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Optimum Clinical |
| Contact Person: | Linda Loeffelbein |
| Address: | 2318 Atkinsen St, Amarillo, Texas 79106 |
| Phone Number: | (913) 689-9265 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Nonmetallic Minerals Development and Test Boring |
| SIC Code: | 1481 |
| NAICS Code: | 213115 |
| Share This Business: |
Optimum Clinical was started in 2012 to provide professional Nonmetallic Minerals Development and Test Boring under the SIC code 1481 and NAICS code 213115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Linda Loeffelbein for inquiries that concern Optimum Clinical by calling the company number (913) 689-9265, as your correspondence is most welcome. Additionally, the physical location of the single location of Optimum Clinical can be found at the coordinates 35.186224,-101.900199 as well as the street address 2318 Atkinsen St in Amarillo, Texas 79106.
For its online presence, you may visit Optimum Clinical’s website at and engage with its social media outlets through on Twitter and on Facebook.